IRCT20111119008129N13已完成3 期
Evaluation of the effects of resveratrol consumption on inflammatory and biochemical parameters of patients with Covid ??
Boushehr University of Medical Sciences0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Female and Male with the age between 18 to 55 years
- •Long involvement approved by city scan
- •Admitted to the hospital with Fever( = 38 C°)
- •The breath rate = 24/min, or coughing ( before the 8th day of the disease )
- •Infection with covid 19, approved by PCR
排除标准
- •Pregnant women
- •Patients with kidney Disease,
- •Patients with hypercalcemia and hypercalciuria
- •Patients with any type of allergic diseases
- •Having any kind of disease by which the patients can't have a proper participation
- •Inability to behave properly( having Mental problem
- •Auto immune diseases ( having MS, Lupus ...)
- •Kidney Failure, Hepatitis B and C
- •Patients with acute covid 19 symptoms
研究者
相似试验
招募中
3 期
Resveratrol in multiple sclerosisMultiple sclerosisMultiple Sclerosis.IRCT20230315057731N1Ahvaz University of Medical Sciences60
已完成
3 期
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
已完成
2 期
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
招募中
不适用
Effect of herbal medicine, Resveratrol, on gingival infectioIRCT20171015036782N6Yazd University of Medical Sciences40